Multifocal C-cell Hyperplasia and Marked Hypercalcitoninemia in a Diabetic Patient Treated With Glucagon-Like Peptide-1 Agonist With Concurrent Multinodular Goiter and Hyperparathyroidism

Thyroid C-cell hyperplasia (CCH) is divided into physiologic or reactive CCH and neoplastic CCH. Glucagon-like peptide-1 receptor agonists (GLP-1 Ra) is a group of medications used to treat type 2 diabetes that has documented C-cell stimulation effect in rodents, leading to subsequent CCH and medull...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Sifan, McDow, Alexandria D, Saeed, Zeb, Hou, Tieying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898871/
https://www.ncbi.nlm.nih.gov/pubmed/36751230
http://dx.doi.org/10.7759/cureus.33384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898871/
https://www.ncbi.nlm.nih.gov/pubmed/36751230
http://dx.doi.org/10.7759/cureus.33384

Ejemplares similares